Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells
Tóm tắt
Asthma causes significant morbidity worldwide in adults and children alike, and incurs large healthcare costs. The statin drugs, which treat hyperlipidemia and cardiovascular diseases, have pleiotropic effects beyond lowering cholesterol, including immunomodulatory, anti-inflammatory, and anti-fibrotic properties which may benefit lung health. Using an allergic mouse model of asthma, we previously demonstrated a benefit of statins in reducing peribronchiolar eosinophilic inflammation, airway hyperreactivity, goblet cell hyperplasia, and lung IL-4 and IL-13 production. In this study, we evaluated whether simvastatin inhibits IL-13-induced pro-inflammatory gene expression of asthma-related cytokines in well-differentiated primary mouse tracheal epithelial (MTE) cell cultures. We hypothesized that simvastatin reduces the expression of IL-13-inducible genes in MTE cells. We harvested tracheal epithelial cells from naïve BALB/c mice, grew them under air-liquid interface (ALI) cell culture conditions, then assessed IL-13-induced gene expression in MTE cells using a quantitative real-time PCR mouse gene array kit. We found that simvastatin had differential effects on IL-13-mediated gene expression (inhibited eotaxin-1; MCP-1,-2,-3; and osteopontin (SPP1), while it induced caspase-1 and CCL20 (MIP-3α)) in MTE cells. For other asthma-relevant genes such as TNF, IL-4, IL-10, CCL12 (MCP-5), CCL5 (RANTES), and CCR3, there were no significant IL-13-inducible or statin effects on gene expression. Simvastatin modulates the gene expression of selected IL-13-inducible pro-inflammatory cytokines and chemokines in primary mouse tracheal epithelial cells. The airway epithelium may be a viable target tissue for the statin drugs. Further research is needed to assess the mechanisms of how statins modulate epithelial gene expression.
Tài liệu tham khảo
Liao JK, Laufs U: Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005, 45: 89-118. 10.1146/annurev.pharmtox.45.120403.095748.
Greenwood J, Steinman L, Zamvil SS: Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol. 2006, 6 (5): 358-370. 10.1038/nri1839.
Alexeeff SE, Sparrow D, Vokonas PS, Schwartz J: Statin use reduces decline in lung function: VA Normative Aging Study. Am J Respir Crit Care Med. 2007, 176: 742-747. 10.1164/rccm.200705-656OC.
Mancini GB, Zhang B, Levesque LE, FitzGerald JM, Brophy JM: Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol. 2006, 47 (12): 2554-2560. 10.1016/j.jacc.2006.04.039.
Ishida W, Ishii M, Fujiwara F, Taneichi H, Takebe N, Takahashi K, Kaneko Y, Segawa I, Kajiwara T, Inoue H, Satoh J: Decrease in Mortality Rate of Chronic Obstructive Pulmonary Disease (COPD) with Statin Use: A Population-Based Analysis in Japan. J Exp Med. 2007, 212 (3): 265-273.
Young RP, Hopkins R, Eaton TE: Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence. Postgrad Med J. 2009, 85 (1006): 414-421. 10.1136/pgmj.2008.078477.
Blamoun AI, DeBari VA, Rashid AO, Sheikh M, Khan MA: Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract. 2008, 62 (9): 1373-1378. 10.1111/j.1742-1241.2008.01731.x.
Hothersall EJ, Chaudhuri R, McSharry C, et al: Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax. 2008, 63 (12): 1070-1075. 10.1136/thx.2008.100198.
Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ: Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2,3-dioxygenase. J Allergy Clin Immunol. 2010, 126 (4): 754-762. 10.1016/j.jaci.2010.08.005.
Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR: Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax. 2010, 65 (10): 891-896. 10.1136/thx.2010.138990.
Zeki AA, Franzi L, Last J, Kenyon NJ: Simvastatin Inhibits Airway Hyperreactivity: Implications for the Mevalonate Pathway and Beyond. Am J Respir Crit Care Med. 2009, 180: 731-740. 10.1164/rccm.200901-0018OC.
Zeki AA, Bratt JM, Rabowsky M, Last JA, Kenyon NJ: Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: A novel treatment for airway remodeling?. Transl Res. 2010, 156 (6): 335-349. 10.1016/j.trsl.2010.09.003.
Ou XM, Wen FQ, Feng YL, Huang XY, Xiao J: Simvastatin attenuates lipopolysaccharide-induced airway mucus hypersecretion in rats. Chin Med J. 2008, 121 (17): 1680-1687.
Vukelic S, Stojadinovic O, Pastar I, et al: Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor. J Biol Chem. 2010, 285 (3): 1980-1988. 10.1074/jbc.M109.016741.
Murphy DM, Corris PA, Johnson GE, Small T, Jones D, Fisher AJ, Egan JJ, Cawston TE, Ward C, Lordan JL: Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients. Am J Physiol Lung Cell Mol Physiol. 2008, 294: 592-599.
Wang W, Le W, Ahuja R, Cho DY, Hwang PH, Upadhyay D: Inhibition of Inflammatory Mediators: Role of Statins in Airway Inflammation. Otolaryngol Head Neck Surg. 2011, 144 (6): 982-987. 10.1177/0194599811400367.
Sakoda K, Yamamato M, Negishi Y, Liao JK, Node K, Izumi Y: Simvastatin decreases IL-6 and IL-8 production in epithelial cells. J Dent Res. 2006, 85 (6): 520-523. 10.1177/154405910608500608.
Wu S, Duan S, Zhao S, Cai Y, Chen P, Fang X: Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells. Respir Res. 2005, 6: 27-10.1186/1465-9921-6-27.
Sakamoto N, Hayashi S, Mukae H, Vincent R, Hogg JC, van Eeden SF: Effect of atorvastatin on PM10-induced cytokine production by human alveolar macrophages and bronchial epithelial cells. Int J Toxicol. 2009, 28 (1): 17-23. 10.1177/1091581809333140.
Kreiselmeier NE, Kraynack NC, Corey DA, Kelley TJ: Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2003, 285 (6): L1286-L1295.
Iwata A, Shirai R, Ishii H, et al: Inhibitory Effect of Statins on Inflammatory Cytokine Production from Human Bronchial Epithelial Cells. Clin Exp Immunol. 2012, 168 (2): 234-240. 10.1111/j.1365-2249.2012.04564.x.
Kraynack NC, Corey DA, Elmer HL, Kelley TJ: Mechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2002, 283 (3): L604-L611.
Robinson CB, Wu R: Culture of Conducting Airway Epithelial in Serum-Free Medium. J Tissue Cult Meth. 1991, 13 (20): 95-102.
Wu R, Nolan E, Turner C: Expression of tracheal differentiated functions in serum-free hormone-supplemented medium. J Cell Physiol. 1985, 125 (2): 167-181. 10.1002/jcp.1041250202.
You Y, Richer EJ, Huang T, Brody SL: Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. Am J Physiol Lung Cell Mol Physiol. 2002, 283 (6): L1315-L1321.
McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY: A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol. 2004, 172 (5): 2903-2908.
Kim DY, Ryu SY, Lim JE, Lee YS, Ro JY: Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol. 2007, 557: 76-86. 10.1016/j.ejphar.2006.11.027.
Ahmad T, Mabalirajan U, Sharma A, et al: Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma. Am J Respir Cell Mol Biol. 2011, 44 (4): 531-539. 10.1165/rcmb.2010-0041OC.
Holgate ST: Epithelium dysfunction in asthma. J Allergy Clin Immunol. 2007, 120: 1233-1244. 10.1016/j.jaci.2007.10.025.
Holgate ST: The Airway Epithelium is Central to the Pathogenesis of Asthma. Allergol Int. 2008, 57: 1-10. 10.2332/allergolint.R-07-154.
Konno S, Kurokawa M, Uede T, Nishimura M, Huang S-K: Role of osteopontin, a multifunctional protein, in allergy and asthma. Clin Exp Allergy Rev. 2011, 41 (10): 1360-1366. 10.1111/j.1365-2222.2011.03775.x.
Schneider DJ, Lindsay JC, Zhou Y, Molina JG, Blackburn MR: Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease. FASEB. 2010, 24 (1): 70-80. 10.1096/fj.09-140772.
Sabo-Attwood T, Ramos-Nino ME, Eugenia-Ariza M, et al: Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis. Am J Pathol. 2011, 178 (5): 1975-1985. 10.1016/j.ajpath.2011.01.048.
Samitas K, Zervas E, Vittorakis S, et al: Osteopontin expression and relation to disease severity in human asthma. Eur Respir J. 2011, 37 (2): 331-341. 10.1183/09031936.00017810.
Delimpoura V, Bakakos P, Tseliou E, et al: Increased levels of osteopontin in sputum supernatant in severe refractory asthma. Thorax. 2010, 65 (9): 782-786. 10.1136/thx.2010.138552.
Simoes DCM, Xanthou G, Petrochilou K, Panoutsakopoulou V, Roussos C, Gratziou C: Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma. Am J Respir Crit Care Med. 2009, 179 (10): 894-902. 10.1164/rccm.200807-1081OC.
Xanthou G, Alissafi T, Semitekolou M, et al: Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med. 2007, 13 (5): 570-578. 10.1038/nm1580.
Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J: The structure of human macrophage inflammatory protein-3a/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human b-defensins. J Biol Chem. 2002, 277 (40): 37647-37654. 10.1074/jbc.M203907200.
Yang D: Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol. 2003, 74 (3): 448-455. 10.1189/jlb.0103024.
Shimada K, Crother TR, Karlin J, et al: Caspase-1 dependent IL-1β secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection. PLoS One. 2011, 6 (6): e21477-10.1371/journal.pone.0021477.
Thomas PG, Dash P, Aldridge JR, et al: The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity. 2009, 30 (4): 566-575. 10.1016/j.immuni.2009.02.006.
Kumar S: Caspases and their many biological functions. Cell Death Differ. 2006, 14 (1): 1-2.
Imamura M, Okunishi K, Ohtsu H, Nakagome K, Harada H, Tanaka R, Yamamoto K, Dohi M: Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitization, interleukin 17 production and antigen presentation in the lung. Thorax. 2009, 64: 44-49.
Fessler MB, Jeyaseelan S, Lieber JG, Arndt PG, Nick JA, Worthen GS, Young SK: A role for hydroxy methylglutaryl coenzyme A reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med. 2005, 171 (6): 606-615.
Y-Juan C, Chen P, Wang H-Xia, et al: Simvastatin attenuates acrolein-induced mucin production in rats: Involvement of the Ras / extracellular signal-regulated kinase pathway. Int Immunopharmacol. 2010, 10 (6): 685-693. 10.1016/j.intimp.2010.03.012.
Barnes PJ: The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest. 2008, 118 (11): 3546-3556. 10.1172/JCI36130.
Anderson GP: Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008, 372 (9643): 1107-1119. 10.1016/S0140-6736(08)61452-X.
Cho S-H, Stanciu L, Holgate ST, Johnston SL: Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med. 2005, 171 (3): 224-230.
Dvorak A, Tilley AE, Shaykhiev R, Wang R, Crystal RG: Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome?. Am J Respir Cell Mol Biol. 2011, 44 (4): 465-473. 10.1165/rcmb.2009-0453OC.
Hirota J, Hackett T-L, Inman MD, Knight D: Modeling asthma in mice: what have we learned about the airway epithelium?. Am J Respir Cell Mol Biol. 2011, 44 (4): 431-438. 10.1165/rcmb.2010-0146TR.